5th Annual Global College of Neuroprotection and Neuroregeneration

Expert Review of Neurotherapeutics

Volumn 8, Issue 6, 2008, Pages 881-887

  Sharma, Hari Shanker ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMPHETAMINE; AMYLOID BETA PROTEIN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; AP 267; BOTULINUM TOXIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CEREBROLYSIN; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; FENTANYL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; H 290 51; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; LEVODOPA; MOOD STABILIZER; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEOSTIGMINE; NEUROPROTECTIVE AGENT; PARVOVIRUS VECTOR; PROBENECID; RIMONABANT; SIBUTRAMINE; SUFENTANIL; TACROLIMUS; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTONOMIC NEUROPATHY; BLOOD BRAIN BARRIER; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONFERENCE PAPER; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; HUMAN; LEUKOENCEPHALOPATHY; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRION DISEASE; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

EUROPE; NERVE REGENERATION; NERVOUS SYSTEM DISEASES; NEUROLOGY; NEUROPROTECTIVE AGENTS; REGENERATIVE MEDICINE;

EID: 45749127309     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.6.881     Document Type: Conference Paper

References (13)

1. Ren J, Sietsma D, Qiu S, Moessler H, Finklestein SP. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Restor. Neurol. Neurosci. 25(1), 25-31 (2007).
2. Sharma HS, Johanson CE. Blood-cerebrospinal fluid barrier in hyperthermia. Prog. Brain Res. 162, 459-478 (2007).
3. Sharma HS, Patnaik R, Patnaik S, Mohanty S, Sharma A, Vannemreddy P. Antibodies to serotonin attenuate closed head injury induced blood brain barrier disruption and brain pathology. Ann. NY Acad. Sci. 22, 295-312 (2007).
4. Sharma HS. Neurotrophic factors in combination: a possible new therapeutic strategy to influence pathophysiology of spinal cord injury and repair mechanisms. Curr. Pharm. Des. 13(18), 1841-1874 (2007).
5. Sharma HS. Methods to produce hyperthermia-induced brain dysfunction. Prog. Brain Res. 162, 173-199 (2007).
6. Sharma HS. Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomed. 2(6), 753-758 (2007).
7. Sharma HS, Ali SF, Dong W et al. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord. Ann. NY Acad. Sci. 22, 197-218 (2007).
8. Sharma HS, Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res. 162, 245-273 (2007).
9. Quintero EM, Willis LM, Zaman V et al. Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience 124(1), 137-146 (2004).
10. Sharma HS, Sjöquist PO, Ali SF. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr. Pharm. Des. 13(18), 1903-1923 (2007).
11. Nase G, Helm PJ, Enger R, Ottersen OP. Water entry into astrocytes during brain edema formation. Glia 56(8), 895-902 (2008).
12. Slikker W Jr, Zou X, Hotchkiss CE et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol. Sci. 98(1), 145-158 (2007).
13. Kiyatkin EA, Brown PL, Sharma HS. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur. J. Neurosci. 26(5), 1242-1253 (2007).